campaign contributions

Money Talks, and What It’s Saying May Harm the FDA

, sr. Washington rep., Center for Science & Democracy

Any way you look at it, $700 million is a lot of cash. That’s the amount that industries regulated by the FDA have spent since 2009 lobbying Congress and the Executive Branch. That investment is paying off as Congress now considers must-pass legislation that governs how the FDA uses science to evaluate prescription drugs and medical devices. Read more >

Bookmark and Share